Ticker CYDYListed on OTC
CytoDyn Inc.
At a glance
Most recent filing on October 20, 2026 — a grant by Hoffman Robert E. on Oct 20, 2026.
We hold 1 Form 4 line, going back to October 20, 2026.
Insider trades
How to read a Form 4All 1 shown
- Hoffman Robert E. Chief Executive Officer2,500,000 sharesGrant
CEO pay
What the company reported for its principal executive officer, usually the CEO, in the pay-versus-performance table of its proxy statement. The total counts shares and options at their value on the day they were granted. Actually paid counts them at the change in their value during the year, so it can be far higher or lower than the total, and negative. A dash means the company reported no amount.
Jacob Lalezari, fiscal year ended May 31, 2026: total $1,833,398, actually paid $1,537,230. First reported Sep 28, 2026.
Earlier fiscal years are part of the subscription.